Goodwin Advises City Therapeutics on Pricing of $200 Million Upsized Initial Public Offering
October 16, 2026
October 16, 2026
BOSTON, Massachusetts, Oct. 16 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:
* * *
Goodwin Advises City Therapeutics on Pricing of $200 Million Upsized Initial Public Offering
*
The Life Sciences team advised City Therapeutics, Inc. (Nasdaq: CTY) ("City" or "City Therapeutics") on the pricing of its upsized initial public offering of 11,111,111 shares of its common stock at a public offe . . .
* * *
Goodwin Advises City Therapeutics on Pricing of $200 Million Upsized Initial Public Offering
*
The Life Sciences team advised City Therapeutics, Inc. (Nasdaq: CTY) ("City" or "City Therapeutics") on the pricing of its upsized initial public offering of 11,111,111 shares of its common stock at a public offe . . .